Terms: = Breast cancer AND SMO, Q99835, 6608, ENSG00000128602, SMOH, Gx AND Clinical Outcome
2 results:
1. Hedgehog-mesenchyme gene signature identifies bi-modal prognosis in luminal and basal breast cancer sub-types.
Torres-García W; Domenech M
Mol Biosyst; 2017 Nov; 13(12):2615-2624. PubMed ID: 29034935
[TBL] [Abstract] [Full Text] [Related]
2. DNA methyltransferase inhibitor CDA-2 synergizes with high-dose thiotepa and paclitaxel in killing breast cancer stem cells.
Lu Z; Jia J; Di L; Song G; Yuan Y; Ma B; Yu J; Zhu Y; Wang X; Zhou X; Ren J
Front Biosci (Elite Ed); 2011 Jan; 3(1):240-9. PubMed ID: 21196304
[TBL] [Abstract] [Full Text] [Related]
